Xiaobing Deng

2.2k total citations
39 papers, 1.8k citations indexed

About

Xiaobing Deng is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Xiaobing Deng has authored 39 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 16 papers in Oncology and 7 papers in Organic Chemistry. Recurrent topics in Xiaobing Deng's work include Cancer-related Molecular Pathways (7 papers), Synthesis and biological activity (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Xiaobing Deng is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Synthesis and biological activity (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Xiaobing Deng collaborates with scholars based in United States, China and Germany. Xiaobing Deng's co-authors include Eileen Friedman, Daina Z. Ewton, Stephen E. Mercer, Luhua Lai, Xiaowen Xie, José Pedro Friedmann Angeli, Zhongfa Yan, Yonglong Zou, Seunghwan Lim and Ying Liu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Cell Biology and Development.

In The Last Decade

Xiaobing Deng

39 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobing Deng United States 24 1.2k 436 300 222 195 39 1.8k
Sabina Cosulich United Kingdom 26 2.0k 1.6× 526 1.2× 336 1.1× 290 1.3× 253 1.3× 55 2.6k
Debra A. Tonetti United States 26 935 0.8× 662 1.5× 245 0.8× 150 0.7× 178 0.9× 57 1.7k
Wenlin Shao United States 14 1.5k 1.2× 480 1.1× 238 0.8× 147 0.7× 178 0.9× 27 2.0k
Scott T. Eblen United States 24 1.8k 1.5× 445 1.0× 218 0.7× 152 0.7× 148 0.8× 41 2.3k
Janeen H. Trembley United States 23 1.3k 1.1× 611 1.4× 187 0.6× 165 0.7× 100 0.5× 72 1.9k
James S. Hardwick United States 18 1.7k 1.4× 454 1.0× 200 0.7× 170 0.8× 269 1.4× 25 2.5k
Holly Edwards United States 28 1.7k 1.4× 383 0.9× 210 0.7× 108 0.5× 186 1.0× 69 2.2k
Christine M. Chresta United Kingdom 21 1.5k 1.2× 827 1.9× 335 1.1× 207 0.9× 136 0.7× 33 2.1k
Douglas C. Marchion United States 23 1.8k 1.5× 609 1.4× 253 0.8× 155 0.7× 156 0.8× 66 2.3k
Honyin Chiu United States 6 1.3k 1.1× 400 0.9× 318 1.1× 281 1.3× 308 1.6× 7 2.0k

Countries citing papers authored by Xiaobing Deng

Since Specialization
Citations

This map shows the geographic impact of Xiaobing Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobing Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobing Deng more than expected).

Fields of papers citing papers by Xiaobing Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobing Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobing Deng. The network helps show where Xiaobing Deng may publish in the future.

Co-authorship network of co-authors of Xiaobing Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobing Deng. A scholar is included among the top collaborators of Xiaobing Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobing Deng. Xiaobing Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ying, Jun, et al.. (2024). Mitochondrial modulation treating postoperative cognitive dysfunction neuroprotection via DRP1 inhibition by Mdivi1. Scientific Reports. 14(1). 26155–26155. 4 indexed citations
2.
Connell, Marisa, et al.. (2024). Kin17 regulates proper cortical localization of Miranda in Drosophila neuroblasts by regulating Flfl expression. Cell Reports. 43(3). 113823–113823. 2 indexed citations
3.
Deng, Xiaobing, et al.. (2022). The Ets protein Pointed P1 represses Asense expression in type II neuroblasts by activating Tailless. PLoS Genetics. 18(1). e1009928–e1009928. 2 indexed citations
4.
Deng, Xiaobing, Xiaoling Zhang, Bo Tang, et al.. (2018). Design, Synthesis, and Evaluation of Dihydrobenzo[cd]indole-6-sulfonamide as TNF-α Inhibitors. Frontiers in Chemistry. 6. 98–98. 13 indexed citations
5.
Li, Cong, Xiaobing Deng, Xiaowen Xie, et al.. (2018). Activation of Glutathione Peroxidase 4 as a Novel Anti-inflammatory Strategy. Frontiers in Pharmacology. 9. 1120–1120. 154 indexed citations
6.
Deng, Xiaobing, et al.. (2016). Expression of TLE-1 and CD99 in Carcinoma: Pitfalls in Diagnosis of Synovial Sarcoma. Applied immunohistochemistry & molecular morphology. 26(6). 368–373. 22 indexed citations
7.
Deng, Xiaobing, Jing Hu, Daina Z. Ewton, & Eileen Friedman. (2014). Mirk/dyrk1B kinase is upregulated following inhibition of mTOR. Carcinogenesis. 35(9). 1968–1976. 25 indexed citations
8.
Shang, Erchang, Yiran Wu, Pei Liu, et al.. (2014). Benzo[d]isothiazole 1,1-dioxide derivatives as dual functional inhibitors of 5-lipoxygenase and microsomal prostaglandin E2 synthase-1. Bioorganic & Medicinal Chemistry Letters. 24(12). 2764–2767. 30 indexed citations
9.
Shen, Qi, et al.. (2014). Discovery of highly potent TNFα inhibitors using virtual screen. European Journal of Medicinal Chemistry. 85. 119–126. 12 indexed citations
10.
Deng, Xiaobing, et al.. (2014). The normal function of the cancer kinase Mirk/dyrk1B is to reduce reactive oxygen species. Genes & Cancer. 5(1-2). 22–30. 22 indexed citations
11.
Ewton, Daina Z., Jing Hu, Maria Vilenchik, et al.. (2011). Inactivation of Mirk/Dyrk1b Kinase Targets Quiescent Pancreatic Cancer Cells. Molecular Cancer Therapeutics. 10(11). 2104–2114. 56 indexed citations
12.
Deng, Xiaobing, Ning Chen, Zhixin Wang, et al.. (2011). A Convenient Synthesis of Thiazolidin-2-ones from Thiazolidine-2-thiones: Antibiotic Activity and Revisiting the Mechanism. Phosphorus, sulfur, and silicon and the related elements. 186(7). 1563–1571. 11 indexed citations
13.
Yu, Hao, Xiaobing Deng, Shengli Cao, & Jiaxi Xu. (2011). Practical Corey-Chaykovsky Epoxidation: Scope and Limitation. Letters in Organic Chemistry. 8(7). 509–514. 6 indexed citations
14.
Deng, Xiaobing, Daina Z. Ewton, & Eileen Friedman. (2009). Mirk/Dyrk1B Maintains the Viability of Quiescent Pancreatic Cancer Cells by Reducing Levels of Reactive Oxygen Species. Cancer Research. 69(8). 3317–3324. 80 indexed citations
15.
Mercer, Stephen E., Daina Z. Ewton, Xiaobing Deng, et al.. (2005). Mirk/Dyrk1B Mediates Survival during the Differentiation of C2C12Myoblasts. Journal of Biological Chemistry. 280(27). 25788–25801. 81 indexed citations
16.
Deng, Xiaobing, et al.. (2004). The Cyclin-dependent Kinase Inhibitor p27Kip1 Is Stabilized in G0 by Mirk/dyrk1B Kinase. Journal of Biological Chemistry. 279(21). 22498–22504. 116 indexed citations
17.
Deng, Xiaobing, Daina Z. Ewton, Stephen E. Mercer, & Eileen Friedman. (2004). Mirk/dyrk1B Decreases the Nuclear Accumulation of Class II Histone Deacetylases during Skeletal Muscle Differentiation. Journal of Biological Chemistry. 280(6). 4894–4905. 61 indexed citations
18.
Deng, Xiaobing, Daina Z. Ewton, Bradley Pawlikowski, Margaret M. Maimone, & Eileen Friedman. (2003). Mirk/dyrk1B Is a Rho-induced Kinase Active in Skeletal Muscle Differentiation. Journal of Biological Chemistry. 278(42). 41347–41354. 80 indexed citations
19.
Ewton, Daina Z., et al.. (2002). Rapid turnover of cell‐cycle regulators found in Mirk/dyrk1B transfectants. International Journal of Cancer. 103(1). 21–28. 28 indexed citations
20.
Yan, Zhongfa, Xiaobing Deng, & Eileen Friedman. (2001). Oncogenic Ki-ras Confers a More Aggressive Colon Cancer Phenotype through Modification of Transforming Growth Factor-β Receptor III. Journal of Biological Chemistry. 276(2). 1555–1563. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabina Cosulich Breakdown of academic impact, for papers by Debra A. Tonetti Breakdown of academic impact, for papers by Wenlin Shao Breakdown of academic impact, for papers by Scott T. Eblen Breakdown of academic impact, for papers by Janeen H. Trembley Breakdown of academic impact, for papers by James S. Hardwick Breakdown of academic impact, for papers by Holly Edwards Breakdown of academic impact, for papers by Christine M. Chresta Breakdown of academic impact, for papers by Douglas C. Marchion Breakdown of academic impact, for papers by Honyin Chiu
Rankless by CCL
2026